reference/5124019

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5124019

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	751
issn	0923-7534
issueIdentifier	4
pageRange	745-751
publicationName	Annals of oncology : official journal of the European Society for Medical Oncology
startingPage	745
bibliographicCitation	Boeck S, Weigang-Köhler K, Fuchs M, Kettner E, Quietzsch D, Trojan J, Stötzer O, Zeuzem S, Lordick F, Köhne CH, Kröning H, Steinmetz T, Depenbrock H, Heinemann V. Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial. Ann Oncol. 2007 Apr;18(4):745–51. doi: 10.1093/annonc/mdl463. PMID: 17229775.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ccdcd2d1c8bdde6b3b817e32b5893a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ce5f6907694abc69a3e664404b5b6ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf46f1d63d6e9b4820dc558386e3a91a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c722224eee6c4464c2a854148c3f5153 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_952bf97f9904088325205513bb61e78c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3256ebe98472e13c96e556b831edf063 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b560f62583aa096870b83fbe137adedd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29ea86e8d6676178bdc342ccf2affce2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12f579f7937e8151c9366f085e7ffb68 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66b2436ef29f479d91e2da723ab8ea6e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cd637faaa9e9610ab634ed395da844a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_efa96441e5e6e77b17097732cefa5675 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fde1de78cd9e365bd233477b49da4e53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42a8917bfa61b1033eba62cf8fd26611
date	200704
identifier	https://pubmed.ncbi.nlm.nih.gov/17229775 https://doi.org/10.1093/annonc/mdl463
isPartOf	https://portal.issn.org/resource/ISSN/0923-7534 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial
discusses	http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0027621 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0009376
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010190Q000188 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D005971Q000627 http://id.nlm.nih.gov/mesh/D003841Q000031
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D010190Q000097 http://id.nlm.nih.gov/mesh/D006147Q000627 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D003841Q000627 http://id.nlm.nih.gov/mesh/D010190Q000401 http://id.nlm.nih.gov/mesh/D006147Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005971Q000009 http://id.nlm.nih.gov/mesh/D018395Q000097 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8866 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621

Total number of triples: 75.